Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
about
Repurposing metformin: an old drug with new tricks in its binding pocketsDiabetes mellitus and metformin in hepatocellular carcinomaFrom obesity to diabetes and cancer: epidemiological links and role of therapiesObesity and cancer: at the crossroads of cellular metabolism and proliferationDissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesPharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 StudiesConventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis.Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol.Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.The role of obesity in oesophageal cancer development.Metformin and breast and gynecological cancer risk among women with diabetes.Use of noninsulin anti diabetics for prevention and treatment of cancer- narrative review article.Association between Insulin Monotherapy versus Insulin plus Metformin and the Risk of All-Cause Mortality and Other Serious Outcomes: A Retrospective Cohort StudyCancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator.Risk factors for cancer development in type 2 diabetes: A retrospective case-control studyAssociation of diabetes and diabetes treatment with incidence of breast cancer.Repurposing old drugs to chemoprevention: the case of metformin.Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic StudyMetformin and cancer in type 2 diabetes.Effects of sulfonylureas on tumor growth: a review of the literature.Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer.Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention.New insight for metformin against bladder cancer.Diabetes and cancer relationships.Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis.Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.Antihyperglycaemic therapies and cancer risk.Metformin: risk-benefit profile with a focus on cancer.Cancer Prevention: Lessons Learned and Future Directions.Repurposing metformin for the prevention of cancer and cancer recurrence.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.Enemies or weapons in hands: investigational anti-diabetic drug glibenclamide and cancer risk.Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.Combination of metformin and valproic acid synergistically induces cell cycle arrest and apoptosis in clear cell renal cell carcinoma.Use of statins offsets insulin-related cancer risk.Differential effects of metformin on age related comorbidities in older men with type 2 diabetes.No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.Recent advances in the use of metformin: can treating diabetes prevent breast cancer?Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta-analysis.
P2860
Q22250976-D2B2959F-D342-4014-90DD-6B94882BE9D3Q26741205-CF2B2F57-7716-4736-9531-02D83ACC85A2Q26767027-42D98F4B-CB90-4391-869C-CE53D2D84588Q27003989-65BE679A-8DBB-409F-81E8-B998F6E6CF48Q28081491-F98956CA-1576-4B9C-90D0-3D50B7A5330CQ28084927-DBA8A150-8415-4421-82D1-28617B028402Q33748862-A646A240-B3CA-4413-B0C2-65482D817024Q33830390-651EC8AB-E950-4BF6-95CA-114A827E067AQ34135248-0F0BBFF9-9D74-44C2-A893-AF640CEE08E8Q34418740-D2E9DD0D-9434-487B-AF32-3049851FE96EQ35046074-8E1CC38B-AC4F-45CF-8017-16AEDD5B3BEAQ35466765-BAF34DC5-C114-4BC1-BBD8-30CCF5502A3CQ36010556-892FC110-6E43-4671-92EE-71801B2EAE57Q36024628-B7346DCA-20A9-4318-8F82-559C178C7D7DQ36159846-C64DE441-C76E-46D6-8B48-1C13B90E8460Q36568614-D032BBA9-B8E0-4AFA-AB38-CEF3D89F8782Q36679911-E9A855E3-72E4-4BBD-9F77-DB4DCF1354F2Q36712191-18C1F1BE-415B-41E3-A037-6693DDBDA492Q36800716-26DF3D49-1516-4927-8098-D64D89EECF4AQ37247194-08ED4870-1342-4C75-8371-36BDD0F78FC9Q37521408-02EC4CBC-8D3A-4F82-AEA4-161418FA9565Q37608817-8931A6C2-ED6F-4008-A718-AF969B1B1939Q37733377-FB147051-50C9-40D7-857B-4007FD35614FQ38097984-E021879C-1C99-4831-8975-FC0686490A3CQ38163451-F53EE6A2-1D5C-4744-81E2-3BB720C8482DQ38185970-B265D122-FC05-4588-97BA-252E835E6766Q38250719-18AF6C1B-FC54-493D-ABC6-1CD762CDA1CDQ38584636-0C8B363B-3A32-4A1A-8F25-338F00A7936BQ38652183-D599EAEE-B02B-4FEB-A18E-5079B061DB00Q38695734-B88F4AFD-DC30-41A5-AF12-7ED26D89F772Q38728567-FB4DF62E-D8D9-4FB0-9592-89C73947DE5CQ38765310-BA7B221A-DB96-43BA-B739-FAC26D99F6BAQ38858585-0BF88926-3E36-4F6E-ADEC-93473BD7CEA5Q38867200-4EAAD7EE-E846-4222-BCF7-E1DC50261C17Q39263827-EE7A8F6A-8954-410A-8695-889ECF4E3262Q40338946-73BBDE2A-4C3C-409E-9C6F-C54713B6E73BQ40778391-10E37522-6B06-408E-A63D-B2EA10D6D5CFQ41050215-9B2D6EBC-1FCE-4DC2-83A2-9FA305568DF3Q41083568-970ECF83-BB0F-4B36-8789-768E91095967Q41303279-B56BB596-F8F8-42F8-9C68-5CCFE492666B
P2860
Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Metformin and sulfonylureas in ...... ary data of published studies.
@ast
Metformin and sulfonylureas in ...... ary data of published studies.
@en
type
label
Metformin and sulfonylureas in ...... ary data of published studies.
@ast
Metformin and sulfonylureas in ...... ary data of published studies.
@en
prefLabel
Metformin and sulfonylureas in ...... ary data of published studies.
@ast
Metformin and sulfonylureas in ...... ary data of published studies.
@en
P2093
P1433
P1476
Metformin and sulfonylureas in ...... ary data of published studies.
@en
P2093
Bindiya Thakkar
Christos S Mantzoros
Kelsey Shields
Maria T Vamvini
P304
P356
10.1016/J.METABOL.2013.01.014
P577
2013-02-16T00:00:00Z